One of the first international firms to modify Acerinox’s target price once its possible merger with Aperam became known, Credit Suisse, gives free rein to its increases by revising upwards the clearly bullish expectations that it previously considered.
Investors reacted last Friday to the confirmation of the negotiations for a possible merger between Acerinox and Aperam with a stock market correction in the first of these companies and a resounding rise in Aperam. But analysts don’t.
